#patientinput
LightNews LightNews
survivornetca.bsky.social
#dostarlimab #jemperli #atezolizumab #tecentriq #patientvoice #HTA #chemotherapy #patientinput #patient #survivor #caregiver #survey #HTAsubmission #colorectalcancer #cancer #colorectal #colon #rectal #treatment #therapy #realworldevidence #patientexperience
September 25, 2026 at 2:01 PM
survivornetca.bsky.social
#ProstateCancer #MetastaticProstateCancer #CancerAdvocacy #PatientVoice #PatientInput #CancerCare #CancerCommunity #HealthPolicy #HTA #Cancer
May 7, 2026 at 7:32 PM
melindamosheim.bsky.social
Patient Advocates & Patient Relations: Dedicated advocates help bridge the gap between clinical staff and patients, ensuring your voice is heard, answering questions, and addressing concerns. Contact the Patient Relations department by calling (813) 745-3808 or emailing patientinput@moffitt.org
June 17, 2026 at 7:36 PM
acejointhealth.bsky.social
JointHealth™ express - Call for patient input on ruxolitinib (Opzelura®) for atopic dermatitis. Learn more: bit.ly/ACE_CDAPatie...

#AtopicDermatitis #PatientInput

@arthritispower.bsky.social @schroeder-uhn.bsky.social @arthritistrainees.bsky.social @arthritis-ubc.bsky.social
Call for patient input on ruxolitinib (Opzelura®) for atopic dermatitis - Arthritis News
If you live with atopic dermatitis or care for someone with atopic dermatitis, please send us your input by April 2, 2026. Your input will be anonymous.
bit.ly
March 18, 2026 at 5:24 PM
acejointhealth.bsky.social
JointHealth™ express - Call for patient input on inebilizumab (Uplizna®) for immunoglobulin G4-related disease.

Learn more: bit.ly/ACE_CDAPatie...

#patientinput @schroeder-uhn.bsky.social @arthritispower.bsky.social @arthritistrainees.bsky.social @arthritisdietitian.bsky.social
Call for patient input on inebilizumab (Uplizna®) for immunoglobulin G4-related disease - Arthritis News
If you live with immunoglobulin G4-related disease or care for someone with immunoglobulin G4-related disease, please send us your input by March 19, 2026.
bit.ly
March 11, 2026 at 4:55 PM
acejointhealth.bsky.social
JointHealth™ express - Let BC PharmaCare hear Your Voice on sarilumab (Kevzara®) for the treatment of polymyalgia rheumatica in adults. Learn more: bit.ly/JHEBCYourVoi...

#patientinput @arthritispower.bsky.social @arthritis-ubc.bsky.social @fraserhealth.ca @providencehealthcare.org
Let BC PharmaCare hear Your Voice on sarilumab (Kevzara®) for the treatment of polymyalgia rheumatica in adults - Arthritis News
You can give input if you are a B.C. resident and an adult living with polymyalgia rheumatica, a caregiver to an adult living with polymyalgia rheumatica, or if your group represents adults living wit...
bit.ly
February 23, 2026 at 7:20 PM
acejointhealth.bsky.social
JointHealth™ express - Call for patient input on anifrolumab (Saphnelo®) for systemic #lupus erythematosus.

Learn more: bit.ly/ACECDAPatien...

#SLE #patientinput #ACEAdvocacy @arthritispower.bsky.social @lupuschat.bsky.social @fibroandlupus.bsky.social @schroeder-uhn.bsky.social
Call for patient input on anifrolumab (Saphnelo®) for systemic lupus erythematosus - Arthritis News
If you are a patient or caregiver of someone living with systemic lupus erythematosus, we want to hear from you!
bit.ly
December 22, 2025 at 11:06 PM
acejointhealth.bsky.social
JointHealth™ express - Call for patient input on roflumilast (Zoryve®) for plaque psoriasis. Send your input to feedback@jointhealth.org.

Learn more: bit.ly/JHECDAPatien...

#patientinput #plaquepsoriasis
Call for patient input on roflumilast (Zoryve®) for plaque psoriasis - Arthritis News
If you are a patient or caregiver of someone living with plaque psoriasis, we want to hear from you!
bit.ly
November 11, 2025 at 5:08 PM
acejointhealth.bsky.social
JointHealth™ express - Let BC PharmaCare hear Your Voice on upadacitinib (Rinvoq®) for the treatment of giant cell arteritis.

Learn more: bit.ly/JHEBCYourVoi...

#GCA #patientinput

@arthritistrainees.bsky.social
@arthritisdietitian.bsky.social
@inesss.qc.ca
@arthritispower.bsky.social
Let BC PharmaCare hear Your Voice on upadacitinib (Rinvoq®) for the treatment of giant cell arteritis - Arthritis News
BC PharmaCare is looking for your input on upadacitinib (Rinvoq®) for the treatment of giant cell arteritis.
bit.ly
November 5, 2025 at 3:05 PM
acejointhealth.bsky.social
JointHealth™ express - Let BC PharmaCare hear Your Voice on roflumilast cream (Zoryve®) for the treatment of atopic dermatitis in patients 6 years of age and older.

Learn more: bit.ly/JHEBCYourVoi...

#patientinput

@arthritispower.bsky.social
@schroeder-uhn.bsky.social
@lupuschat.bsky.social
Let BC PharmaCare hear Your Voice on roflumilast cream (Zoryve®) for the treatment of atopic dermatitis in patients 6 years of age and older - Arthritis News
BC PharmaCare is looking for your input on roflumilast cream (Zoryve®) for the treatment of atopic dermatitis in patients 6 years of age and older.
bit.ly
November 4, 2025 at 4:55 PM
acejointhealth.bsky.social
JointHealth™ express - Call for patient input on upadacitinib (Rinvoq) for giant cell arteritis. Send your input to feedback@jointhealth.org. Learn more: bit.ly/CDAupadaciti...

#GCA #patientinput @schroeder-uhn.bsky.social @arthritispower.bsky.social @ualberta.bsky.social @arthritis-ubc.bsky.social
May 14, 2025 at 9:37 PM
capa-aca.bsky.social
Today is the last day to complete our survey about living with polymyalgia rheumatica (PMR)! This is your chance to share your experience and help shape access to treatment.

Learn more + add your voice: buff.ly/2LUuZry

#PMR #Kevzara #PatientInput #PatientVoice
October 6, 2025 at 1:03 PM